CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 7, 2007, Pages 1011-1015

  Ji, Bian Sheng ^a   He, Ling ^b  

^a HENAN UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; ISOFLAVONE; ISOFLAVONE CYJ; RHODAMINE 123; UNCLASSIFIED DRUG; VERAPAMIL;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIDRUG RESISTANCE; MYELOID LEUKEMIA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUORESCENCE; HUMANS; ISOFLAVONES; K562 CELLS; P-GLYCOPROTEIN; RHODAMINE 123;

EID: 34447342246     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.7.0014     Document Type: Article

References (15)

1. Belhoussine, R., Morjani, H., Sharonov, S., Ploton, D., Manfait, M. (1999) Characterization of intracellular pH gradients in human multidrug-resistant tumor cells by means of scanning microspectrofluorometry and dual-emission-ratio probes. Int. J. Cancer 81: 81-89
2. Bezombes, C., Maestre, N., Laurent, G., Levade, T., Bettaieb, A., Jaffrezou, J. P. (1998) Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J. 12: 101-109
3. Briffod, M., Spyratos, F., Hacene, K., Tubiana-Hulin, M., Pallud, C., Gilles, F., Rouesse, J. (1992) Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis. Cytometry 13: 250-258
4. Ferte, J., Kuhnel, J. M., Chapuis, G., Rolland, Y., Lewin, G., Schwaller, M. A. (1999) Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure-activity relationships. J. Med. Chem. 42: 478-489
5. Gong, J., Traganos, F., Darzynkiewicz, Z. (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218: 314-319
6. Gottesman, M. M., Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385-427
7. Gottlieb, R. A., Nordberg, J., Skowronski, E., Babior, B. M. (1996) Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc. Natl. Acad. Sci. U.S.A. 93: 654-658
8. Green, L. J., Marder, P., Slapak, C. A. (2001) Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells. Biochem. Pharmacol. 61: 1393-1399
9. Hansen, M. B., Nielsen, S. E., Berg, K. (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119: 203-210
10. Ikegawa, T., Ushigome, F., Koyabu, N., Morimoto, S., Shoyama, Y., Naito, M., Tsuruo, T., Ohtani, H., Sawada, Y. (2000) Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones, in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett. 160: 21-28
11. Johnstone, R. W., Cretney, E., Smyth, M. J. (1999) P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93: 1075-1085
12. Kitagawa, S. (2006) Inhibitory effects of polyphenols on p-glycoprotein-mediated transport. Biol. Pharm. Bull. 29: 1-6
13. Patanasethanont, D., Nagai, J., Yumoto, R., Murakami, T., Sutthanut, K., Sripanidkulchai, B. O., Yenjai, C., Takano, M. (2007) Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function. J. Pharm. Sci. 96: 223-233
14. Sorenson, C. M., Eastman, A. (1988) Mechanism of cis- diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks. Cancer Res. 48: 4484-4488
15. Twentyman, P. R. (1988) Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins. Br. J. Cancer 57: 254-258